Affiliation:
1. Biological Sciences and Technology Division CSIR-North East Institute of Science and Technology Jorhat 785006 Assam India
2. Academy of Scientific and Innovative Research (AcSIR) Ghaziabad 201002 India
3. Center for Infectious Diseases CSIR-North East Institute of Science and Technology Jorhat 785006 Assam India
Abstract
AbstractMesoporous silica nanoparticles (MSNs) are promising nanomaterials that are widely used in biomedical applications like drug delivery, diagnosis, bio‐sensing and cell tracking. MSNs have been investigated meticulously in the drug‐delivery field due to their unique chemical and pharmacokinetic properties, such as highly ordered mesopores, high surface area and pore volume, tuneable pore size, stability, surface functionalisation, and biocompatibility. MSN‐based nanocomposites have been used to deliver therapeutic molecules like insulin, GLP‐1, exenatide, DPP‐4 inhibitor and plasmid‐containing GLP‐1 genes for managing diabetes mellitus for the last decade. The functionalisation properties of MSNs make them substantially capable of the co‐delivery, controlled delivery and stimuli‐responsive delivery of antidiabetic drugs. This review focuses on the delivery of antidiabetic therapeutics with special emphasis on the functionalisation of MSNs and stimuli‐responsive delivery.
Subject
Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献